MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Akers Biosciences Company Profile (NASDAQ:AKER)

Consensus Ratings for Akers Biosciences (NASDAQ:AKER) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Akers Biosciences (NASDAQ:AKER)
DateFirmActionRatingPrice TargetActions
6/9/2014AegisInitiated CoverageBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/4/2013 forward)